MODERN APPROACHES TO THE USE OF MUCOLYTIC AND BRONCHODILATOR AGENTS IN ACUTE RESPIRATORY VIRAL INFECTIONS WITH BRONCHIAL OBSTRUCTION IN CHILDREN

Read full text Summarise with VIRAT
Authors: Abdullayeva Dilmura Axmadullayevna
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In children with acute respiratory viral infections, the lower respiratory tract is often involved, leading to the development of bronchial obstruction. The use of the combined preparation Ascoril Expectorant (bromhexine + salbutamol + guaifenesin), due to its combined bronchodilator and mucolytic effects, results in rapid regression of disease symptoms, prevents progression to a more severe and prolonged course, and subsequently reduces the need for antibiotic therapy. The clinical efficacy and favorable safety profile of Ascoril Expectorant allow it to be recommended as the drug of choice for children over 2 years of age with mild to moderate bronchial obstruction associated with ARVI.

Fields of Study & Subjects

Pediatric health and respiratory diseases Respiratory and Cough-Related Research Respiratory viral infections research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 March 2026
Language
EN
Document type
Dataset